Wave Life Sciences Ltd. Logo

Wave Life Sciences Ltd.

Developing RNA-based medicines for severe genetic diseases like DMD and Huntington's disease.

WVE | US

Overview

Corporate Details

ISIN(s):
USY953081053 (+1 more)
LEI:
Country:
United States of America
Address:
7 STRAITS VIEW, 18936 SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Wave Life Sciences Ltd. is a clinical-stage biotechnology company dedicated to developing transformative RNA-based medicines for genetically defined diseases. The company leverages its proprietary PRISM® platform, which combines chemistry innovation and deep insights in human genetics, to create stereopure oligonucleotide therapeutics. Wave's pipeline focuses on advancing first- or best-in-class treatments for severe conditions with high unmet medical needs. Key therapeutic areas include Duchenne muscular dystrophy (DMD), Huntington's disease, Alpha-1 antitrypsin deficiency (AATD), and obesity. The company's mission is to deliver life-changing therapies for patients with both rare and common disorders.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Wave Life Sciences Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Wave Life Sciences Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Wave Life Sciences Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cuprina Holdings (Cayman) LTD Logo
Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.
United States of America
CUPR
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea
365270
Curanex Pharmaceuticals Inc Logo
Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.
United States of America
CURX
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany
CVAC
CureVac N.V. Logo
Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.
United States of America
CVAC
CURIS INC Logo
Biotech developing innovative cancer therapeutics for hematologic malignancies.
United States of America
CRIS
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea
372320
CYBIN INC. Logo
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
United States of America
CYCN

Talk to a Data Expert

Have a question? We'll get back to you promptly.